Skip to main content
. 2020 Jan 2;29(6):323–334. doi: 10.3233/VES-190683

Table 1.

Demographic information for the participants with UVD who completed the study

ID Age Gender Time from initial symptoms to start of study Group Designation
1 64 M 50 months Control
2 47 F 10.5 months Control
3 67 F 324 months Control
4 68 F 31 months Experimental
5 63 F 26.5 months Experimental
6 79 M 16 months Experimental
7 74 F 79.5 months Control
8 63 F 46 months Experimental